Nirsevimab Library
Universal Level Designations for Hospitalized Pediatric Patients in Evacuation
2022
· American Academy of Pediatrics (AAP),
· Stanford University,
· University of Washington,
· Western Regional Alliance for Pediatric Emergency Management (WRAP-EM),
· Oregon Health & Science University,
· University of California San Francisco
This article describes a proposal for a 4-tier system to classify pediatric hospital beds during disasters. It highlights the need for clear definitions to manage …
Ask aRCie
Pediatric Medical Countermeasures: Antidotes and Cytokines for Radiological and Nuclear Incidents and Terrorism
2024
· Arizona Poison and Drug Information Center,
· Western Regional Alliance for Pediatric Emergency Management (WRAP-EM),
· Emory University,
· Southern Regional Disaster Response System,
· Intermountain Primary Children's Hospital,
· University of Nebraska Medical Center,
· University of California San Francisco,
· Stanford University,
· Arizona Department of Health Services
This article addresses the lack of studies comparing pediatric indications and dosing for medical countermeasures in radiological and nuclear incidents. Children are especially vulnerable in …
Protecting Kids from Wildfire Smoke: Actions for California Schools
· Stanford Medicine,
· Stanford University,
· Western States Pediatric Environmental Health Specialty Unit (PEHSU),
· American Academy of Pediatrics (AAP),
· U. S. Environmental Protection Agency,
· Centers for Disease Control and Prevention (CDC),
· U.S. Environmental Protection Agency
This document emphasizes the urgent need for schools to protect children's health amidst intensifying smoke and wildfire seasons, alongside addressing indoor air quality improvements crucial …
COVID-19 Preparedness - A Survey Among Neonatal Care Providers in Low- and Middle-Income Countries
2021
· The Arctic University of Norway,
· Stanford University,
· California Perinatal Quality Care Collaborative,
· Policlinico of Milan,
· University of Oxford,
· University of Vermont,
· Sanatorios de la Trinidad
This study assessed neonatal care providers' preparedness during the COVID-19 pandemic, based on a survey conducted in 69 low- and middle-income countries. Results showed challenges …
Successful Implementation of Nirsevimab and Factors Influencing Uptake in Neonatal Care
This article describes how a hospital successfully used nirsevimab to prevent RSV in newborns. They offered the immunization to 99% of eligible infants, with 71% …
Learning from Wildfire Disaster Experience in California NICUs
2020
· Stanford University
This study examined how hospitals in California, especially neonatal intensive care units (NICUs), learn from wildfires. It describes the challenges these units face during such …
Climate Resilient California Schools
2023
· Stanford University,
· University of California, Berkeley,
· UndauntedK12,
· Ten Strands
This report describes how climate change affects children's health and education in California. It highlights the need for schools to be safe from heat, wildfires, …
Power Outages and Community Health: A Narrative Review
2020
· Columbia University,
· Beth Israel Deaconess Medical Center,
· Harvard T.H. Chan School of Public Health,
· Stanford University
This article is about how power outages can affect community health. It describes moderate evidence that power outages can lead to increased health risks, such …
Effective plans for hospital system response to earthquake emergencies
2020
· Stanford University,
· Princeton University,
· National Institute of Standards and Technology (NIST),
· Universidad Peruana Cayetano Heredia
This journal article describes how hospitals need to be ready for emergencies like earthquakes. It explains that when a big earthquake happens, many people get …
Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists
2024
· Yale School of Medicine,
· Stanford University,
· Seattle Children's Hospital,
· The University of Chicago Medicine,
· Nationwide Children's Hospital,
· Yale University
This article discusses the implementation of newly developed nirsevimab into clinical practice. Approved in July 2023, it is costly and has supply issues. Hospitals struggle …